In patients with septic bursitis the indications for admission and surgical intervention remain unclear, and practice has varied widely. The effectiveness of a conservative outpatient based approach was assessed by an outcome study in a prospective case series. Consecutive patients attending an emergency department with acute swelling of the olecranon or prepatellar bursa were managed according to a structured approach, subjective and objective outcomes being assessed after two to three days, and subsequently as required until clinical discharge. Long-term outcomes were assessed by telephone follow-up for up to eighteen months. 47 patients were included in the study: 22 had septic bursitis, 15 of the olecranon bursa and 7 of the prepatellar bursa.
INTRODUCTION
In published studies of septic bursitis, many patients have been admitted and many have had surgical procedures on the bursa; but the need for these actions is not clear. The aim of this study was to investigate whether these steps could be avoided, with preservation of good clinical outcomes, by following a structured conservative management protocol.
Guidelines have been published on the management of septic bursitis1, but these have not been prospectively evaluated and important questions remain unanswered. Should some patients be admitted for parenteral antibiotic therapy, and should some be treated initially with more aggressive surgical management2? Could needle aspiration of the bursa, as is generally recommended3, be deleterious in some patients by forming sinus tracks that become persistent2'4?
The protocol was intended to be applied to acute bursitis, of whatever cause, affecting the olecranon and prepatellar bursae, from the time of presentation. Distinguishing septic from non-septic bursitis is not always straightforward, either on clinical grounds or by diagnostic tests5, and initial management decisions often have to be made with this uncertainty. The outcomes for patients with both septic and non-septic bursitis were recorded. In a substudy a comparison was made of the diagnostic methods used to identify patients with septic bursitis, including two novel laboratory methods. The results of this comparison have been published separately6.
The design of the main study was a prospective case series, with a defined management strategy and long-term assessment of outcomes. The management strategy was based on current recommendations, with the adoption of specific criteria for admission and surgical intervention and with the aspiration of all bursae. METHOD Recruitment and initial management All patients with an acute swelling of the olecranon or prepatellar bursa seen at an accident and emergency (A&E) department between May 1996 and April 1997 were invited to take part. Patients were seen by the regular medical staff of the department, who had all been instructed in the nature and purpose of the study and the management approaches to be followed. A for each patient agreeing to take part, which in addition to recording clinical details contained step-by-step guidance for the clinician on management. The following details were recorded: duration of symptoms, any trauma, any previous treatment, risk factors either in occupation or in leisure activity (such as kneeling) and in medical history such as alcohol excess, steroid therapy or diabetes. The patient recorded severity of pain on a visual analogue scale (VAS)7 by making a vertical mark on a 1Ocm horizontal line at a point between the left-hand end, labelled 'no pain', and the right-hand end, labelled 'worst pain ever'. The following details were recorded from the clinical examination: temperature, presence and extent of erythema, warmth of affected bursa (graded by the clinician on a three-point scale), degree of tenderness elicited by digital pressure (graded by the patient on a four-point scale), presence of a discharging sinus, and presence of any septic focus in the limb. The affected bursa was aspirated in all cases, from the distal aspect in olecranon bursitis, from the lateral aspect in prepatellar bursitis.
The appearance and volume of fluid aspirated were noted, and it was divided and sent for culture in liquid media (blood culture bottles), direct culture, and white cell counts (haematology cell counter). If gout was suspected clinically, the fluid was also sent for microscopy for crystals. Where the aspirate was purulent and thick, irrigation with normal saline solution through a wide-bore cannula was recommended. Incision and drainage were recommended if a pointing abscess was present. If septic bursitis was considered possible, treatment was started with flucloxacillin, or erythromycin for patients sensitive to penicillin; a ten-day course was recommended for outpatient treatment. Admission for parenteral antibiotic therapy was advised for patients with a temperature greater than 38.0°C or systemic symptoms. In those patients in whom septic bursitis was considered unlikely on clinical grounds, treatment was with aspiration, either alone or with the addition of an oral non-steroidal anti-inflammatory agent, if necessary, for pain.
Clinical follow-up All patients were invited for follow-up at the A&E department two to four days later, when laboratory results were available. They were again asked to mark their degree of pain on a VAS, to describe any change in symptoms on a seven-point scale (much worse to much better) and to specify any difficulties with medication. Findings on examination were recorded in the same way as at presentation, and all data were entered into the study booklets. The recommended management was as at presentation. In addition, for those patients with the diagnosis of non-septic bursitis confirmed by laboratory results, and who remained symptomatic, intrabursal steroids (40 mg methylprednisolone) were given. Further follow-up appointments were arranged as necessary. If a patient did not attend for at least one follow-up appointment the investigator contacted him or her by telephone and asked the same questions.
Long-term follow-up Patients were contacted by telephone about six months after presentation and six monthly thereafter up to eighteen months. Efforts were made to trace patients who had moved home. They were asked: (a) the time from onset to resolution of symptoms; (b) whether pressure on the bursa elicited pain; (c) whether there had been further episodes of bursitis; (d) whether any bursal swelling, lumps or nodules remained palpable; and (e) whether the patient was now able to lean on the elbow or kneel, as appropriate.
Analysis
In the analysis the following patients were excluded: those in whom a definitive diagnosis could not be established because of incomplete laboratory results, and those previously treated with antibiotics. The definitive diagnosis in each case was determined by an independent panel consisting of two senior faculty staff from the departments of orthopaedic surgery and rheumatology, on the basis of all clinical details, laboratory results, and outcomes to the end of clinical follow-up.
The study was approved by the local research ethics committee. RESULTS 57 study booklets were completed and 47 were included in the study (Table 1 ). The remaining 10 were excluded for the following reasons. In 5 a definitive diagnosis could not be firmly established because one or more specimens were either not taken or not analysed; 3 had already received antibiotics; the bursa was not aspirated in one patient, and aspiration did not yield fluid in another. 6 of the 10 excluded patients attended for follow-up; their outcomes were comparable with those of the included patients; no patients were admitted and none had surgical procedures or developed sinuses. Of the 47 patients included, 22 had septic bursitis and the olecranon bursa was affected in about two-thirds of both septic and non-septic bursitis cases. 11 patients had incomplete laboratory data because of inadequate fluid volume for all three analyses but were still judged to have sufficient clinical and laboratory information for a definitive diagnosis to be made. Patients with septic bursitis were typically younger and presented earlier than those with non-septic bursitis; one patient had a predisposing condition, diabetes. The initial treatment based on the clinical diagnosis is shown in Table 1 . Antibiotics were given to all except one patient with septic bursitis and to 7 of the patients ultimately diagnosed as non-septic bursitis. No patients had bursal irrigation or any other surgical procedure at presentation, nor were any admitted at the first attendance. 39 of the 47 patients attended for follow-up. Of the patients with septic bursitis, 2 reported no change in symptoms and 2 reported that their symptoms were much worse ( Table 2 ). These two, both with prepatellar bursitis, were admitted, for two days in each case.
One patient, with septic olecranon bursitis, had surgical intervention. He had been treated with erythromycin and the bursa had been reaspirated three times, but a pointing abscess developed seven days after presentation. It was incised and drained, and the resulting wound healed after a further week. Discharging sinuses developed in 3 patients (Table 3) , all with olecranon bursitis. The clinical features of these patients at presentation were similar to those of patients who did not develop sinuses. In one patient the sinus seemed to have developed because of uncontrolled infection. In the second the bursitis, which appeared to have settled at the end of ten days of antibiotics, gradually worsened again and a sinus developed eight days later. In the third patient, who had a low-grade inflammation, the organism identified, Staphylococcus epidermidis, was accepted as the infective agent only after the identical organism was found on a subsequent reaspiration; this uncertainty led to a delay in the administration of fucidic acid, following a poor response to flucloxacillin alone. These sinuses all developed around the centre of the bursa and not at the site of aspiration. All went on to spontaneous healing. The symptoms of those with non-septic bursitis had generally changed little by the first follow-up, in contrast to the rapid improvements of most of those with septic bursitis. In 8 who remained symptomatic the bursae were reaspirated, and in 7 of these an intrabursal steroid injection was given. All of these 7 went on to an uncomplicated recovery, 3 very rapidly.
One patient had gout affecting the olecranon bursa and described his symptoms as 'much worse' after two days with diclofenac, and then 'much better' five days later after changing to indomethacin.
The number of follow-up appointments attended was greater for those with septic bursitis, partly because those who developed discharging sinuses had to attend frequently. 7 of the 8 not attending the follow-up clinic were contacted by telephone. 6 had not come because their symptoms had improved; one, with septic olecranon bursitis, had attended his family practitioner for further antibiotics and his symptoms settled without complications after three weeks. In the long-term follow-up, 39 of the 47 were successfully traced at least five months post-presentation, and were followed for a mean of 13.8 months (range 5-20) ( Table 4 ). The time taken to recovery was similar for septic and non-septic bursitis, and generally shorter for prepatellar than for olecranon bursitis. Times to symptom recovery were three and four weeks for the 2 patients admitted, ten weeks for the patient whose bursa was incised and seven, eight and ten weeks for the 3 patients with discharging sinuses. Six months from presentation 9 patients still had pain if pressure was applied to the bursa, although all described this as mild. 5 of these became symptom-free by the end of follow-up. In only one patient were these symptoms sufficient to prevent the patient leaning on the elbow. 7 of the patients with non-septic bursitis and one with septic bursitis had recurrent non-septic bursitis during follow-up. These episodes were all mild, and only one episode led to a medical consultation. 13 patients had lumps or other deformity of the bursa at the end of follow-up.
The one patient with gout, not included in Tables 2 and  4 for clarity, was followed up by telephone until 19 months from presentation. His pain resolved after four weeks. The bursa was still mildly tender after six months, but not at the end of follow-up, although a palpable lump remained.
DISCUSSION
The above management strategy for acute bursitis produced good results, with little need for admission or surgical intervention. The admission rate for patients with septic bursitis in this study, 9% (2/22), was much lower than in three previously reported series of septic bursitis (total 121 episodes) where between 48% and 89% were admitted at presentation2'3'9. In a further three series (total 76 episodes) only admitted patients were included4'8' 10. However, these series were either retrospectively identified from case notes or were patients referred to specialists, and so may have been selected series of difficult cases. In these earlier series many more patients had an underlying medical condition (31-71%) than in this study (1 patient) and the average age was higher. Probably many mild cases of bursitis are treated in primary care or in emergency departments and so did not feature in earlier studies.
Surgery was performed in a variable proportion of patients in previous series. None had surgery in one series of 29 patients, and in the other series 8, 10, 19, 23 and 42% had surgery, usually incision and drainage at presentation. No criteria for surgery were stated, and these differences do not seem to be explained by differences in severity. Surgery does not appear to give any advantages, and can probably be avoided in most cases by early aggressive treatment with antibiotics and aspiration. The results in this study favour aspiration of all bursae for diagnosis and as part of treatment. Concern that this may promote the development of sinuses seems unfounded since, where these did occur, they were not at the site of aspiration and developed many days later.
Spontaneous rupture of bursae with sinus formation has been thought undesirable because of the potential for sinuses to become chronic. Thus interventions such as the use of continuous bursal irrigation catheters1l have been recommended for patients with severe septic bursitis. However, identification of patients who may benefit from such intervention is hampered by the difficulty of predicting who will get complications. The duration of symptoms for the septic-bursitis patients in this study was comparable with that reported in 49 patients by Raddatz et al. 2 , who recorded a mean time to 'return to baseline status' of 40 days. Few comparable data are available for non-septic bursitis, but a slow recovery over months has not been unusual12,13* Occupational risk-factors have often been identified in patients with both septic and non-septic bursitis, and these were present in a minority of patients in this study, notably those with prepatellar bursitis. For septic bursitis a typical history is of a break in the skin near the bursa, days earlier, which had often then scabbed over; then after an interval, sudden bursal pain and swelling. This pattern supports the theory that septic bursitis develops when bacteria have passed across the soft tissues from a break in the skin and multiplied within the bursa. Symptoms may develop when there are very few bacteria present, hence the need for more sensitive culture methods to isolate them in some cases. The failure of erytbromycin and repeated aspiration to control the infection in one patient supports the recommendation that bactericidal antibiotics be used where possible for septic bursitis. The use of single intravenous doses of antibiotics for patients with septic bursitis who are otherwise receiving outpatient management with oral antibiotics is worthy of further study. Much higher intrabursal concentrations are likely to be achieved by this approach than with oral therapy alone14.
